Cargando…
Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials
BACKGROUND: Several cancer therapies have been associated with cardiovascular harm in early‐phase clinical trials. However, some cardiovascular harms do not manifest until later‐phase trials. To limit interdisease variability, we focused on breast cancer. Thus, we assessed the reporting of cardiovas...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375478/ https://www.ncbi.nlm.nih.gov/pubmed/35876414 http://dx.doi.org/10.1161/JAHA.121.025206 |